Format

Send to

Choose Destination
See comment in PubMed Commons below
Technol Cancer Res Treat. 2015 Feb;14(1):111-7. doi: 10.7785/tcrt.2012.500404. Epub 2014 Nov 21.

Synthesis and evaluation of hydroxycamptothecin-encapsulated chitosan nanospheres for the treatment of liver cancer.

Author information

  • 1School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, PR China.
  • 2Research Center of Biomedical Engineering, College of Materials, Xiamen University, Xiamen, Fujian 361005, PR China.
  • 3School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, PR China guox@mail.xjtu.edu.cn.

Abstract

Hydroxycamptothecin-encapsulated chitosan (HC) nanospheres were prepared by Shirasu porous glass (SPG) membrane emulsification technique. The properties and morphology of HC nanospheres were characterized. The diameter of the nanospheres could be controlled within a narrow distribution according to the pore-size of SPG membrane. Hydroxycamptothecin (HCPT) encapsulation efficiency could reach to 81.3%. The long-term drug release of HCPT could be presented by an accumulated drug release of 85.4% in 15 days with an initial burst effect. In vitro study, HC showed its anti-tumor ability to human hepatoma (HepG2) cells. In vivo study, HC could reduce tumor weight and growth rate. The results indicated that HC nanospheres prepared by SPG had potential application as a sustained drug delivery system for the treatment of liver cancer.

© The Author(s) 2014.

KEYWORDS:

Chitosan; Drug delivery system; Hydroxycamptothecin; SPG

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk